{"eu_number": "EU-1-21-1541", "parse_date": "2022-11-29 19:27:18.400226", "decisions": [{"filename": "EU-1-21-1541_h_dec_0.pdf", "eu_aut_date": "2022-03-24 00:00:00", "eu_brand_name_initial": "Dasatinib Accordpharma", "eu_brand_name_current": "Not parsed", "active_substance": "dasatinib", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "|->NOT FOUND<-|", "eu_mah_initial": "Accord Healthcare S.L.U.", "eu_aut_type_initial": "|->NOT FOUND<-|", "eu_aut_type_current": "Not parsed"}], "annexes": [{"pdf_file": "EU-1-21-1541_h_anx_0.pdf", "xml_file": "EU-1-21-1541_h_anx_0.xml", "is_initial": true, "creation_date": "D:20190801062500Z", "modification_date": "D:20220203190100Z", "eu_aut_type_initial": "standard", "eu_med_type": "small molecule"}], "epars": [{"filename": "EU-1-21-1541_h_public-assessment-report", "ema_procedure_start_initial": "3/06/2019", "chmp_opinion_date": "27/01/2022", "eu_legal_basis": ["article 10.1"], "eu_prime_initial": "no", "ema_rapp": "john joseph borg", "ema_corapp": "|->NOT FOUND<-|", "ema_reexamination": "no", "eu_accel_assess_g": "no"}], "omars": []}